ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000675.1|(+)-T-muurolol_1 # 1 # 828 # -1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000675.1|(+)-T-muurolol_1 	1	828	-	Loose	800	28.4906	Chlamydia trachomatis intrinsic murA conferring resistance to fosfomycin	22.4	3003785	protein homolog model	n/a	n/a	fosfomycin	antibiotic target alteration	antibiotic-resistant murA transferase	GTGACGGCCGCAGGAGACGACGGCATAGGCACCCCCACCAGCGCCCGCAGCGGGTACGGCGCGGGACTCTTCGACCACCGTCGCCGCCTGGAGGTACAGCGGCTGCGTGCCCTGGAGGCATACAACGACCCCGCGACCCAGTCGGTCATCCTGGCCCGGGGTGTCCAGCCGGGCTGGCGCTGCCTCGAACTCGGCGGCGGAGCAGGGTCCATCGCCCGCTGGCTCGCCGCACACAGCGCCCCCGGAGAGGTCGTCGTCACCGACCTCGACACCCGGCTGCTGCCCCGCGGCATACCCAACCTCACCGTCCTGCGCCACGACGTGGTCCACGACGACTTCCCCGCGGCCTCCTTCGACCTCGTCCACGCCCGCGCCCTGCTCGAACACCTGCCCAAACCCACGGATGTTCTCGCCAAAATGGTCCGCTGGACCGCCCCCGGAGGCTGGGTGTGCGTGGACGACCTGATCTCCATACGCCCGCCCGGCGGCCCGCGCGACGCCCATCAGCGCTGCTGGAACGCGCTCGTCACCCTCGCGGAGGGCACCATGCGGATCGACCAGCACTGGGCCGCCACCCTGCCGCGGCTGTTCGCCGCCCAGGGCCTGACCGACATCGGCGTCCACTGCACCCCCGGCCTGGTGGGAGGGAGCGGCAACGCCACCGAGTTCATCCGGATCGCGCTCGAACAGCTCGGAACGACCCTGGTCGAACGGTGCCTCATCACCGACCGTGACCTCGCCGAAGGCCGTGACCTGCTGGCGGACCCGCACTACAGCGACCTGGTCACCATCACCTTCTCCGCCTGGGGCCGACGCCCCAGTACGTAG	MTAAGDDGIGTPTSARSGYGAGLFDHRRRLEVQRLRALEAYNDPATQSVILARGVQPGWRCLELGGGAGSIARWLAAHSAPGEVVVTDLDTRLLPRGIPNLTVLRHDVVHDDFPAASFDLVHARALLEHLPKPTDVLAKMVRWTAPGGWVCVDDLISIRPPGGPRDAHQRCWNALVTLAEGTMRIDQHWAATLPRLFAAQGLTDIGVHCTPGLVGGSGNATEFIRIALEQLGTTLVERCLITDRDLAEGRDLLADPHYSDLVTITFSAWGRRPST	MPGIKVFGETVLRGSVRVSGAKNATTKLLVASLLSDQRTILKNVPNIEDVRQTVDLCRVLGAIVEWDQQAQVIEIHTPRILLSKVPPQFSCVNRIPILLLGALLRRCPYGIFVPILGGDAIGPRTLHFHLEGWKKLGAEIVISDEGYWASAPNGLVGAHITLPYPSVGATENLILASVGAQGRTIIKNAALEVEIIDLIVFLQKAGVEITTDNDKTIEIFGCQDFYSVEHFIIPDKIEAASFGMAAVVSQGRIFVEQARHEHMIPFLKVLRSIGGGFSVHENGIEFFYDKPLKGGVLLETDVHPGFITDWQQPFAVLLSQSEGCSVIHETVHENRLGYLKGLVKMGAHCDLFHECLSAKSCRYSTGNHPHSAVIHGPTPLQATDLVIPDLRAGFAYVMAALIAEGGASWIENTEMLDRGYTDWRGKLERLGAKVLARDAVSVYV	61.94	gnl|BL_ORD_ID|2414|hsp_num:0	2291		
BGC0000675.1|(+)-T-muurolol_2 # 825 # 1313 # -1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.708	BGC0000675.1|(+)-T-muurolol_2 	825	1313	-	Loose	450	23.483	rmtG	56.25	3002668	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GTGCTCGATGGCCGCCCCGCCCAGCACGACGACCTCCCCGCGCTCGAACTCACCGGCCGGATCATCCAGGAGACGCTGCGCCTCTACCCCTCCGCCTGGCTCTTCACCCGCACCGTCACCACCGACACCGAACTCGGCGGACACCCGCTGCCCGCCCGCAGCACCATCATGTTCAGCGCCTACCAGATCCACCGCCGCGCCGACCTCTACCCCCACCCCGACCGCTTCGACCCCGACCGATGGCTGAACGCCCCCAAACCCCCACCCGGCACCCACCTGCCGTTCAGCAGCGGCCCCCGTAAATGCATCGCCGAGACCTTCGCCCTCAACGAAACCACCCTCGCCCTCGCCACCATCGCCACCCGCTGGCAGCTCGACCCCACCCCCGGACCACCCGTCCGCCCCGCCCGCCACATCACCCTCCAGCCCAAAAAACTCACCATGCGCCTGCGGGAACGAAGCGGCTCCGGTGCGGGCACAGCGCCGTGA	MLDGRPAQHDDLPALELTGRIIQETLRLYPSAWLFTRTVTTDTELGGHPLPARSTIMFSAYQIHRRADLYPHPDRFDPDRWLNAPKPPPGTHLPFSSGPRKCIAETFALNETTLALATIATRWQLDPTPGPPVRPARHITLQPKKLTMRLRERSGSGAGTAP	MRDPLFEKLAASKKYRDVCPDTIARILTECRAKYRREKEIDKAAREKLHGITAAFMTDAEYRRAMEIAVRGGELAELMECHASTRERLPLEETDAVYARLLGAPDESALDLACGLNPAYLQNRYPEMRVTGIDISGQCVRVLRALGVDARLGDLLAENAIPRARYSVALLFKILPLLDRQSAGAARRILEAVNADALICSFPTRSLSGRNVGMAVHYAAWMRDQLPEKWRIERTVETDNELYYVLKEKQDGEAVRGGDSHRESE	61.36	gnl|BL_ORD_ID|1298|hsp_num:0	1382		
BGC0000675.1|(+)-T-muurolol_3 # 1377 # 2180 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.718	BGC0000675.1|(+)-T-muurolol_3 	1377	2180	-	Loose	700	26.9498	cfr(D)	48.15	3005021	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; oxazolidinone antibiotic; phenicol antibiotic	antibiotic target alteration	Cfr 23S ribosomal RNA methyltransferase	GTGAACCCCACCTACACGATGGCGCAGGCGCCGGGCGCGCTGCCCGTGCTCGGCCATGCCGCCGCGTTCGCCCGCCGGCCGCTGGACTTCATCCGGGAGCTGCCCGATCACGGGGACCTGGTGCGGGTCCGGCTGGGCCCGCTGACGGCCCATGTGGTCTGCCATCCCGATCTGCTCCACCGGGTGCTGGCCGAGGACCGTGTCTTCGACAAGGGCGGGCCGGTCTTCGAGACCTTCCGCAAGACCGCGGGCAACGGCCTGCTCGGCTGTCCCGCCCGCGACCACCGCAGGCAGCGCAGACTGGTCCAGCCCGCTTTCCATCGCTCGCGCCTGCCCGGCTACTCGGCCGCCATGGCCGAGGAGATCGCGGCGCTCACCGAGCCCTGGCGGCCCGGCCAGACCCTCGACGTCCCCGCTCTGATGTACCGGCTCACCACCGCCGTGACCACCCGGTGCCTGTTCGCCTCCGCCGCACAGGCGGCCGACCTGCCCTCCCTGCACGAGAGCGTCGACATCGTCACCCAGGGCATCGCCCGGCGTGCCATGCTGCCCGTCCCCGCCCTCCACCGGCTCCCCACCCCGGCCAACCGCCGCTACCAGCGGACACAACGGTACCTGCGGCATCTCACCGACACCCTGATCGACAGCTACCGGACACAAGGCACCGACCAGGGCGATCTGCTGTCGATGCTGCTGGCTCCCCAGGACGACGGCGGACCGGGGCTGACCGGCACCGAGATCCACGACCAGATCCTCACCTTCCTCCTCGCGGGCATCGACACCACGGCCATCCTGCTCTCCTGA	MNPTYTMAQAPGALPVLGHAAAFARRPLDFIRELPDHGDLVRVRLGPLTAHVVCHPDLLHRVLAEDRVFDKGGPVFETFRKTAGNGLLGCPARDHRRQRRLVQPAFHRSRLPGYSAAMAEEIAALTEPWRPGQTLDVPALMYRLTTAVTTRCLFASAAQAADLPSLHESVDIVTQGIARRAMLPVPALHRLPTPANRRYQRTQRYLRHLTDTLIDSYRTQGTDQGDLLSMLLAPQDDGGPGLTGTEIHDQILTFLLAGIDTTAILLS	MLQKQLTKYQQIEKVLKECQQPNYRMKQILHCIFKEKKTDFNEMSVLPKNLRDTLTTEIGTSLLTVEPLIEQKSQQVRKVLFNLSGDNRIETVNMTYQAGWESFCISSQCGCNLGCQFCATGKIGLRKNLTAEEITDQVLYFLLKGHQIDSISFMGMGEPLANPHFFEALDIFMNPDMFQLSPRRLSVSTIGVIPKIKRLTAEYPQVHLTFSLHSPFDEERSQLMPINKSFPLLKVMDTLDEHIKVTSKKVYIAYILLPDVNDSLTHAVALADLLRSRYKKGKLYHVNLIRYNPTFDAPRTFKQVDEKQVKLFYQTLISKGINVTIRSQFGIEIDAACGQLYGNYEIKNKKTIQVND	74.79	gnl|BL_ORD_ID|2813|hsp_num:0	3763		
BGC0000675.1|(+)-T-muurolol_4 # 2177 # 3433 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.705	BGC0000675.1|(+)-T-muurolol_4 	2177	3433	-	Loose	700	28.4906	mef(D)	32.69	3005089	protein homolog model	n/a	n/a		antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGTCCCTGAACCACAGCGATCTGATGTTCTACTGCCCTGTGGACGATCTTCCGCATCCGGCGGCGTCGGGTGTCAATGACCGTACGCTCGACTGGGCGTCCGGGCAGGGGATACCCACGGCGGACCGGGACGCGGGCCGGCTGCGGGCGATGGCGCCGGGTCTGCTGGCGGCCCGTATCGCCCCGGACGCCCGGGGCCCGGTGCTGGACGCTTTCGCGGACCACCACACCTGGCTCTTCGCCTTCGACGACGAGTACTGCGACAGGGCCGACGGTTCCGGCATCACCGAGTGGGCGAGCTTCCTGGCCCGGCTGCACCGGGTGGTGGAGACCGGCGAGAGCGCGCTGCTGCCGGGCAATCCCTACGGCCTCGCCCTGCGTGACATCGCCTGCCGGCTCTCCACGTACACGACACCGGCCCAGCTCGCCGAATGGCTCGAAGCCCTGCGGTCCTACTTCGCCGCCCTGGTCTGGGAACGCTCCCGCCGCCGCGACGACGACCGGCTCCAGAGCCTCGACGACTATCTGCTGCTCCGCCTCCGCAACGGCGCGATGCACACCAGCATCACCCTCCTGGACACCGTCAACGGCTACGTCCTGCCACGCGAGCTGCGGGAAACACCGGGCGTACGCGCCCTGGTCGAGATGACCGCGCTTCTCGTCTCGGTGGACAACGACATCCTCTCGCACCACAAGGAGTCCACGAGCGGGACCCGGGAGGCCAATCTCCTCGATGTGCTCGGCCGGACGGGGCACACCACCCCCGGGGAAGCCGTAGCCCAGGCCGTCGCCCTGCGCAATGAGATCATGCGTCAATTCGTGCGCGTGGCCGAACGAGTCCGGACCCCCGCCGCCGTCCCGGAGCTGTACCGTTTCACCACGGGTCTCGCCCGCTGGATACGGGCCAACCTGGACTTCAGCCTCACCACCACCCGCTACACCGGTCCGGTCACCGAACGCGCCGCCCTCAGCCCGCATGAGGTTCCTCCCCTGTCGGGGCAGGGGCCCGCCCCCGCCCGGTCGGACGTGATCGGCTGGTGGTGGCGGATACCGGAGCCCCTCCCCGAGCCGGGCTCCGATGGCGCTGACACGCCGGTGAGGAAACGCCGTGCCGGGGATCGCCCACCCACGGCAGGCAGGGGCGGCGCTCCCCACCACCAGCGGACGGGGCCACCGCCACCCGTTCTCCCGGGCGGAATCACGGCCAGTCGGTCATCCGGGTTGCAGCAGTCGACATGGAGGCGTGAGCACCGGTGA	MSLNHSDLMFYCPVDDLPHPAASGVNDRTLDWASGQGIPTADRDAGRLRAMAPGLLAARIAPDARGPVLDAFADHHTWLFAFDDEYCDRADGSGITEWASFLARLHRVVETGESALLPGNPYGLALRDIACRLSTYTTPAQLAEWLEALRSYFAALVWERSRRRDDDRLQSLDDYLLLRLRNGAMHTSITLLDTVNGYVLPRELRETPGVRALVEMTALLVSVDNDILSHHKESTSGTREANLLDVLGRTGHTTPGEAVAQAVALRNEIMRQFVRVAERVRTPAAVPELYRFTTGLARWIRANLDFSLTTTRYTGPVTERAALSPHEVPPLSGQGPAPARSDVIGWWWRIPEPLPEPGSDGADTPVRKRRAGDRPPTAGRGGAPHHQRTGPPPPVLPGGITASRSSGLQQSTWRREHR	MKNNKWKKKFIAIYIGQFFSLLSSAAVQFSIIWWLTDKTGGSPLVLTLAGLAGFLPQALAGPFAGTITDRYSRKLMMILADMTVALGSLILFISLYFYEINISFVILILAIRSLATAFHMPALQASIPLLVPEDDLTKAAGWGQTVSSISNITGPAVGMSILAASSIEWVLLLDVLGAVIASGILLFIYIPKIQNQNQQSIDSKGFFIEMKDGYNALVNHPILLKLTFVMTSVAVLYIPLGTYFPLITRNHFNKGVVEAGIVEIIFAVGLIIGGSFLGILGDKFNKINTMTTGILLMGIALFLTGILSPSLFYFFVVLAGLVGFSGPLFSAPFYALIQSEIEPHLLGRVFSFVTSISLLATPLGYVIAGLLIEITNVSTLFSIIGVLIIFNGIIINRLK	104.76	gnl|BL_ORD_ID|2867|hsp_num:0	3823		
BGC0000675.1|(+)-T-muurolol_5 # 3639 # 4976 # -1 # ID=1_5;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000675.1|(+)-T-muurolol_5 	3639	4976	-	Loose	525	27.7202	OXA-444	32.0	3003600	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	CTGCCCGCGCCGCCCGTCGCTCCGGGGCGGCTCCCGGTCCTGGGGCATCTCGTCGCCATGCTCCGTGATCCTCTCGGGTTCATGGCGTCCTTGCCGGCCGTGGCCGAGGTGGTCACCATCTATGTCGGGACGCGGCCGGTCCATGTCGCCAACTCGCTCGATCTGGTCCAGTCCATGCTGGTCACCGAGGCCGACAGCTTTCAGCGCGGACTGTTGTTCGAGAAGGCCGAGAAGGTCGTGGGTCCCGGTCTGACCATGGTCGAGGGGGAGGCGCACAGGAGGCAGCGCAAGCTGGTCCAGCCGGCGTTCAGCCCGCGCCGGATCGAGCAGTACACCCAGACGATGATCGAGGCGGCGGAGGCCGGAGTCGGCTCCTGGCGGCCGGGCCGGAGGATGGACGCGGACCGGGTGATGTACGACCTCGGCATGGACGTCTTCACCCGGGTACTGTTCCGCGGCGCGCTCGACGGCGCATCGGCGGACCTGGTGAAGCAGGCGACCTCCGGCATCATGGCCGGGATGGTCGCGCACTCGCTCTATCCGGCGCAGTGGCTGGAGAAGGTGCCGATCCCGCTCAATCGCCGGTTCCGGCGTGGCGACGCGCAGATGACCGAGGTGGTCGACCGGATCATCCACCACTACCGGCAGGGCGGCACGGCCGACCACGACGGGGCGGCGATCCTCGACGCGTTGATGGCCGAGAACGAGCGGGCGAGCGGTCGGCCCCTGGACTCCGTGGAACTGCGGACCGAGGTCATTCATCTCCTGGTCGCCGGCGCCGAAGGGCCCGGCGCGTCCCTGGCCTGGCTGTTCCACGAGCTGAGCCGGCACCCCGACGTCGAACGGCAGCTGGTGGAGGAACTCGACGCCGTCTTCGGGGACGGCCCCCTCACCGTGGCGGGGCTCGCCGGTCTCACCTTCACCCGGGCCGTGGTGAAGGAATCCCTGCGCGTCCACGCCCCGACCTGGCTGCTGACCCGCCGTGCCCTGAAGGCCGTCGCCCTCGGTGGGCACCGCATTCCGGCCGGTGGCGAGGTCGCTTTCAGCCTCACCGCGCTGCACCGCACCGCGCCGCAGTACGACGACCCCGGGCGCTTCGACCCGGCGCGCTGGCTGGACGGCCGGACGGCGCGTCTGCCGCGCAGCGCGTACATGCCCTTCGGAACCGGCAGGCACCGATGCGTGGGCGACCACTTCACCCTCCAGGTGGTCCTGGTCTGTGCCGTGACCATCGCCCGGCGGTGGCGGCTCGTGCCGTGCCCCGGAATCCGTGTCCGGGAGAGGCCGGTGGCGCTGGTGCGGCCAAGTGGTCTCCTCATGGACGTGGCGGCCCGGTAG	LPAPPVAPGRLPVLGHLVAMLRDPLGFMASLPAVAEVVTIYVGTRPVHVANSLDLVQSMLVTEADSFQRGLLFEKAEKVVGPGLTMVEGEAHRRQRKLVQPAFSPRRIEQYTQTMIEAAEAGVGSWRPGRRMDADRVMYDLGMDVFTRVLFRGALDGASADLVKQATSGIMAGMVAHSLYPAQWLEKVPIPLNRRFRRGDAQMTEVVDRIIHHYRQGGTADHDGAAILDALMAENERASGRPLDSVELRTEVIHLLVAGAEGPGASLAWLFHELSRHPDVERQLVEELDAVFGDGPLTVAGLAGLTFTRAVVKESLRVHAPTWLLTRRALKAVALGGHRIPAGGEVAFSLTALHRTAPQYDDPGRFDPARWLDGRTARLPRSAYMPFGTGRHRCVGDHFTLQVVLVCAVTIARRWRLVPCPGIRVRERPVALVRPSGLLMDVAAR	MFSRWSKPLVLAATVCAMAMSAATAHAELIVRNDLKRVFDEAGVSGTFVLMDISADRTYVVDPARAARRIHPASTFKIPNSLIAFDTGAVRDDHEVLPYGGKPQPYKQWEHDMALPEAIRLSAVPIYQEVARRVGLERMQAYVDAFDYGNRQLGSVIDQFWLRGPLEISALEEARFTSRMALKQLPVKPRTWDMVHRMLLIEQQGDAALYAKTGVATEYQPEIGWWVGWVERAGRVYAFALNIDMPREGDMAKRIPLGKQLMQALDVWPVL	164.21	gnl|BL_ORD_ID|2341|hsp_num:0	3514		
